Description:Health Innovation Capital (HIC) is a distinguished venture capital impact fund dedicated to investing in transformative healthcare innovations aimed at addressing the unmet medical needs of pediatric patients, particularly within the fields of oncology, infectious diseases, and select rare and orphan designations. The firm is comprised of a tenured, diverse, and cohesive team of venture investors and medical innovation executives who have collaboratively financed and propelled some of the healthcare industry’s most significant technological advancements and service innovations.
With a collective experience of over 125 years, the team at Health Innovation Capital boasts a remarkable track record of achieving substantial exits and generating impressive returns within its targeted indications and health sectors. HIC's commitment to success is further bolstered by its scientific and medical advisors, who include leading physicians, C-suite executives, and researchers. This combination positions the firm as a recognized thought leader and enabler in the advancement of innovative solutions throughout the pediatric patient journey—spanning prevention, diagnosis, treatment, and ongoing care.
In addition to their investment efforts, Health Innovation Capital demonstrates a strong commitment to the advancement of pediatric health innovation through the establishment of the HIC Foundation. This foundation channels 10% of the fund's General Partner Carry Interest to esteemed centers of pediatric care, further underscoring HIC's dedication to improving health outcomes for children.